Your browser doesn't support javascript.
loading
High frequency of inactivating tetraspanin C D37 mutations in diffuse large B-cell lymphoma at immune-privileged sites.
Elfrink, Suraya; de Winde, Charlotte M; van den Brand, Michiel; Berendsen, Madeleine; Roemer, Margaretha G M; Arnold, Frank; Janssen, Luuk; van der Schaaf, Alie; Jansen, Erik; Groenen, Patricia J T A; Eijkelenboom, Astrid; Stevens, Wendy; Hess, Corine J; van Krieken, J Han; Vermaat, Joost S P; Cleven, Arjen H G; de Groen, Ruben A L; Neviani, Viviana; de Jong, Daphne; van Deventer, Sjoerd; Scheijen, Blanca; van Spriel, Annemiek B.
Afiliación
  • Elfrink S; Department of Tumor Immunology and.
  • de Winde CM; Department of Tumor Immunology and.
  • van den Brand M; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Berendsen M; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Roemer MGM; Amsterdam UMC-Vrije Universiteit Amsterdam, Department of Pathology and Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Arnold F; Department of Tumor Immunology and.
  • Janssen L; Department of Tumor Immunology and.
  • van der Schaaf A; Department of Tumor Immunology and.
  • Jansen E; Department of Tumor Immunology and.
  • Groenen PJTA; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Eijkelenboom A; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Stevens W; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Hess CJ; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Krieken JH; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Vermaat JSP; Department of Hematology and.
  • Cleven AHG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands; and.
  • de Groen RAL; Department of Hematology and.
  • Neviani V; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands; and.
  • de Jong D; Crystal and Structural Chemistry, Department of Chemistry, Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands.
  • van Deventer S; Amsterdam UMC-Vrije Universiteit Amsterdam, Department of Pathology and Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Scheijen B; Department of Tumor Immunology and.
  • van Spriel AB; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Blood ; 134(12): 946-950, 2019 09 19.
Article en En | MEDLINE | ID: mdl-31366619

Texto completo: 1 Colección: 01-internacional Asunto principal: Linfoma de Células B Grandes Difuso / Tetraspaninas / Privilegio Inmunológico / Antígenos de Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Blood Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Linfoma de Células B Grandes Difuso / Tetraspaninas / Privilegio Inmunológico / Antígenos de Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Blood Año: 2019 Tipo del documento: Article